AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

55.01USD
1 Jul 2013
Price Change (% chg)

$-0.82 (-1.47%)
Prev Close
$55.83
Open
$56.11
Day's High
$56.21
Day's Low
$54.97
Volume
1,179,877
Avg. Vol
694,864
52-wk High
$56.91
52-wk Low
$36.74

ABC.N

Chart for ABC.N

About

AmerisourceBergen Corporation (AmerisourceBergenis) a pharmaceutical services companies serving the United States, Canada, and selected global markets.The Company distributes a range of pharmaceuticalsgeneric pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a... (more)

Overall

Beta: 0.75
Market Cap (Mil.): $12,702.22
Shares Outstanding (Mil.): 230.91
Dividend: 0.21
Yield (%): 1.53

Financials

  ABC.N Industry Sector
P/E (TTM): 19.26 32.01 32.18
EPS (TTM): 2.86 -- --
ROI: 16.09 19.61 18.91
ROE: 26.75 20.45 19.87
Search Stocks

Walgreen to buy stake in AmerisourceBergen, Cardinal loses out

- Walgreen Co and partner Alliance Boots said on Tuesday they signed a 10-year deal with AmerisourceBergen that will include daily drug distribution, enabling Walgreen to increase its sales of pricey specialty drugs.

20 Mar 2013

CORRECTED-UPDATE 5-Walgreen to buy stake in AmerisourceBergen, Cardinal loses out

(Corrects paragraph 8 details of Walgreen and Cardinal generics delivery schedule)

20 Mar 2013

Walgreen to buy stake in AmerisourceBergen, Cardinal loses out

- Walgreen Co and partner Alliance Boots said on Tuesday they signed a 10-year deal with AmerisourceBergen that will include daily drug distribution, enabling Walgreen to increase its sales of pricey specialty drugs.

19 Mar 2013

UPDATE 5-Walgreen to buy stake in AmerisourceBergen, Cardinal loses out

March 19 - Walgreen Co and partner Alliance Boots said on Tuesday they signed a 10-year deal with AmerisourceBergen that will include daily drug distribution, enabling Walgreen to increase its sales of pricey specialty drugs.

19 Mar 2013

UPDATE 3-Walgreen to take stake in AmerisourceBergen, drops Cardinal

March 19 - Walgreen Co and partner Alliance Boots said on Tuesday they signed a 10-year deal with AmerisourceBergen and will take up to a 23 percent stake in the distribution company, ending Walgreen's current contract with Cardinal Health Inc.

19 Mar 2013

RPT-Fitch: Walgreens deal likely positive for AmerisourceBergen; no immediate ratings impact

March 19 - (The following statement was released by the rating agency) The announced long-term strategic agreement among AmerisourceBergen Corp. (ABC), Walgreen Co. (Walgreens), and Alliance Boots GmbH (Alliance Boots) is likely positive for ABC, according to Fitch Ratings. The agreement has no immediate impact on ABC's current 'A-' ratings. A complete list of ABC's ratings is provided at the end of this release. The Rating Outlook is Stable. Fitch expects ABC to remain committed t

19 Mar 2013

BRIEF-AmerisourceBergen up in premarket on distribution deal with Walgreen

NEW YORK, March 19 - AmerisourceBergen Corp : * Up 6.6 percent to $51.50 in premarket on distribution deal with Walgreen Co

19 Mar 2013

BRIEF-Cardinal Health down in premarket after AmerisourceBergen signs 10-year distribution deal with Walgreen

NEW YORK, March 19 - Cardinal Health Inc : * down 5.3 percent to $43.50 in premarket after AmerisourceBergen signs 10-year distribution deal with Walgreen Co

19 Mar 2013

BRIEF-AmerisourceBergen sees revenues up $25 bln in 1st year of Walgreen deal

March 19 - WALGREEN: * Amerisourcebergen corp CEO says deal Walgreen Co to be

19 Mar 2013

AmerisourceBergen signs 10-year distribution deal with Walgreen

March 19 - Pharmaceuticals distributor AmerisourceBergen signed a 10-year distribution contract with Walgreen Co and associate Alliance Boots GmbH that will also allow them to acquire up to 23 percent of AmerisourceBergen.

19 Mar 2013

Competitors

  Price Change
McKesson Corporation (MCK.N) $116.18 +1.68
Cardinal Health Inc (CAH.N) $47.59 +0.39
Henry Schein, Inc. (HSIC.OQ) $97.07 +1.32
Walgreen Company (WAG.N) $44.34 +0.14
Pfizer Inc. (PFE.N) $27.78 -0.23

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$58.00
Provider: Stock Traders Daily
$495.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Market Edge
$10.00
Provider: S&P Capital IQ – STARS Reports
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks